Clinical Trial Results Home

  ST Elevation MI: Facilitated PCI

Glycoprotein IIbIIIa Followed by PCI

 

ADMIRAL Abciximab pre-PCI for STEMI

 

ADVANCE Additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty *Provided by Dr. Valgimigli, University of Ferrara Italy & Erasmus MC, the Netherlands

 

CADILLAC vs ADMIRAL

 

INTAMI Integrilin in Acute Myocardial Infarction

 

STRATEGY Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent vs. Abciximab and Bare-Metal Stent in Myocardial Infarction

 

TETAMI Treatment of Enoxaparin and Tirofiban in Acute Myocardial Infarction

 

TIGER PA Aggrastat before primary PCI

Lytic Followed by PCI

 

ASSENT 4 Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction

 

CAPITAL AMI Combined Angioplasty and Pharmacological Intervention Versus Thrombolytics Alone in Acute Myocardial Infarction

 

GRACIA-2 Safety and efficacy of optimal primary PCI vs facilitated PCI with TNK+stenting in patients with ST elevation MI

 

PACT Half dose tPA before PCI in STEMI

 

 

Rescue PCI for Failed Lysis

 

REACT Rescue Angioplasty Versus Conservative Therapy or

Repeat Thrombolysis Trial